Dengue Author: Suranjith L. Seneviratne, MD, DPhil, MRCP, FRCPath; Panduka Karunanayake, MD, MRCP; Bandula Wijesiriwardena, MD, FRCP, FCCP, FCMSA, FRACP, FACP
Editorial changes - 2009-11-13
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Frequently Asked Questions
Prevention
What measures are indicated to minimize mosquito bites?
Are there risks associated with chemical mosquito repellents?
What precautions are advised in pregnant mothers and children in relation to dengue?
Diagnosis
What is the differential diagnosis of fever or flu-like symptoms in a returned traveler?
How long after a traveler returns home can fever suggest the possibility of dengue?
What clinical features suggest a diagnosis of dengue?
What are the differences between dengue fever and dengue hemorrhagic fever?
What tests are useful in the diagnosis of dengue?
Consultation for Diagnosis
Which specialists should be consulted when dengue is suspected?
Where can information on sample collection and transport for making a diagnosis of dengue be obtained?
If experts in infectious diseases are unavailable, who can be consulted?
Hospitalization
What are the indications for hospital admission in a patient with suspected dengue?
When does a patient with dengue require admission to an ICU?
What kind of monitoring do patients with dengue require?
Non-drug Therapy
What are the indications for intravenous fluids in patients with dengue?
When would a blood transfusion be given in a patient with dengue?
When would platelet infusions be given in patients with dengue?
Drug Therapy
What drugs may be used to treat symptoms of dengue?
Which drugs have not been shown to be useful in patients with dengue?
What are the potential adverse effects of drugs used in patients with dengue?
Patient Education
Do patients with dengue develop immunity that protects them from future exposures to the virus?
How are dengue virus infections transmitted?
What are the long-term effects of dengue?
Consultation for Management
What specialists other than infectious disease experts should be involved in the management of patients with dengue?
If infectious disease experts are unavailable, who can be consulted?
Where can a list of travel clinic specialists in each state of the U.S. be found?
Follow-up
How long should follow-up be continued after hospital discharge?
What tests should be obtained on follow-up?
Is it safe for patients who have had dengue to travel again to a dengue-endemic country?
| Patient Information
Bandula Wijesiriwardena, MD, FRCP, FCCP, FCMSA, FRACP, FACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Panduka Karunanayake, MD, MRCP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Suranjith L. Seneviratne, MD, DPhil, MRCP, FRCPath has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.